Veradermics, Incorporated (MANE)

NYSE: MANE · Real-Time Price · USD

60.85

-4.68 (-7.14%)

At close: Mar 30, 2026, 4:00 PM EDT

61.85

+1.00 (1.64%)

After-hours: Mar 30, 2026, 7:34 PM EDT

Veradermics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-	-26.49	-16.49
Stock-Based Compensation	-	0.25	0.21
Other Operating Activities	-	1.82	1.85
Change in Accounts Payable	-	0.65	1.35
Change in Other Net Operating Assets	-	0.09	-0.43
Operating Cash Flow	-	-23.69	-13.51
Long-Term Debt Issued	-	8.51	-
Long-Term Debt Repaid	-	-0.85	-
Net Debt Issued (Repaid)	-	7.66	-
Other Financing Activities	-	-0.28	-0.04
Financing Cash Flow	-	60.48	13.9
Net Cash Flow	-	36.79	0.39
Cash Interest Paid	-	0.1	-
Levered Free Cash Flow	-	-16.37	-
Unlevered Free Cash Flow	-	-16.01	-
Change in Working Capital	-	0.73	0.92

Updated Jan 28, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q